Clinical Trial: Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
Study Status: Completed
Recruit Status: RECRUITING
Condition: Schizophrenia
Study Type: INTERVENTIONAL
Official Title: Dasatinib Plus Quercetin for Accelerated Aging in Mental Disorders
Brief Summary:
This pilot open-label study examines the effects of a combination of dasatinib plus quercetin - two drugs that have known senolytics properties - on physiological aging in older individuals with depression or schizophrenia.
Read more